Christine J. Saoud

Array ( [id] => 6355316 [patent_doc_number] => 20100022454 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-28 [patent_title] => 'Peptides with High Affinity for the Prolactin Receptor' [patent_app_type] => utility [patent_app_number] => 12/443309 [patent_app_country] => US [patent_app_date] => 2007-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 15892 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20100022454.pdf [firstpage_image] =>[orig_patent_app_number] => 12443309 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6351331 [patent_doc_number] => 20100021900 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-28 [patent_title] => 'USE OF OMENTIN 1 AND OMENTIN 2 IN THE DIAGNOSIS AND TREATMENT OF DISEASE' [patent_app_type] => utility [patent_app_number] => 12/443146 [patent_app_country] => US [patent_app_date] => 2007-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 31409 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20100021900.pdf [firstpage_image] =>[orig_patent_app_number] => 12443146 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4497400 [patent_doc_number] => 07919091 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-04-05 [patent_title] => 'Lipolysis stimulated receptor (LSR) specific antibodies' [patent_app_type] => utility [patent_app_number] => 11/862842 [patent_app_country] => US [patent_app_date] => 2007-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 65 [patent_no_of_words] => 38165 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/919/07919091.pdf [firstpage_image] =>[orig_patent_app_number] => 11862842 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6230028 [patent_doc_number] => 20100184133 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'Method for making maturated insulin polypeptides' [patent_app_type] => utility [patent_app_number] => 12/311431 [patent_app_country] => US [patent_app_date] => 2007-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 15280 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0184/20100184133.pdf [firstpage_image] =>[orig_patent_app_number] => 12311431 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5558748 [patent_doc_number] => 20090270325 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-29 [patent_title] => 'GROWTH FACTOR' [patent_app_type] => utility [patent_app_number] => 12/441361 [patent_app_country] => US [patent_app_date] => 2007-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 5508 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0270/20090270325.pdf [firstpage_image] =>[orig_patent_app_number] => 12441361 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4797105 [patent_doc_number] => 20080008691 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-10 [patent_title] => 'MODIFIED GROWTH HORMONE' [patent_app_type] => utility [patent_app_number] => 11/850947 [patent_app_country] => US [patent_app_date] => 2007-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6372 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20080008691.pdf [firstpage_image] =>[orig_patent_app_number] => 11850947 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5496310 [patent_doc_number] => 20090264338 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-22 [patent_title] => 'Inhibitor of Insulin Multimer Formation' [patent_app_type] => utility [patent_app_number] => 11/849397 [patent_app_country] => US [patent_app_date] => 2007-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6005 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0264/20090264338.pdf [firstpage_image] =>[orig_patent_app_number] => 11849397 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4771852 [patent_doc_number] => 20080057510 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-06 [patent_title] => 'Human Vascular IBP-Like Growth Factor' [patent_app_type] => utility [patent_app_number] => 11/848047 [patent_app_country] => US [patent_app_date] => 2007-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 13004 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0057/20080057510.pdf [firstpage_image] =>[orig_patent_app_number] => 11848047 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4532662 [patent_doc_number] => 07871798 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-01-18 [patent_title] => 'Mammalian cells that express VEGF-D polypeptides' [patent_app_type] => utility [patent_app_number] => 11/843867 [patent_app_country] => US [patent_app_date] => 2007-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 22 [patent_no_of_words] => 15998 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/871/07871798.pdf [firstpage_image] =>[orig_patent_app_number] => 11843867 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6549561 [patent_doc_number] => 20100233135 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-16 [patent_title] => 'COMPOSITIONS AND METHODS FOR HEMATOPOIETIC STEM CELL EXPANSION OR FOR MODULATING ANGIOGENESIS' [patent_app_type] => utility [patent_app_number] => 12/377622 [patent_app_country] => US [patent_app_date] => 2007-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 25809 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20100233135.pdf [firstpage_image] =>[orig_patent_app_number] => 12377622 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4574714 [patent_doc_number] => 07825092 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-11-02 [patent_title] => 'Dendroaspis natriuretic peptide for treatment of cancer' [patent_app_type] => utility [patent_app_number] => 11/833757 [patent_app_country] => US [patent_app_date] => 2007-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5531 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/825/07825092.pdf [firstpage_image] =>[orig_patent_app_number] => 11833757 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4687634 [patent_doc_number] => 20080031815 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-07 [patent_title] => 'Pet imaging of vascular endothelial growth factor receptor (VEGFR), compositions for VEGF cancer imaging, and methods of VEGF cancer imaging' [patent_app_type] => utility [patent_app_number] => 11/881384 [patent_app_country] => US [patent_app_date] => 2007-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 33799 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20080031815.pdf [firstpage_image] =>[orig_patent_app_number] => 11881384 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4792658 [patent_doc_number] => 20080293632 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-27 [patent_title] => 'Use of natriuretic peptides for the treatment of stature disorders related to shox gene' [patent_app_type] => utility [patent_app_number] => 11/822659 [patent_app_country] => US [patent_app_date] => 2007-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 7406 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20080293632.pdf [firstpage_image] =>[orig_patent_app_number] => 11822659 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7591154 [patent_doc_number] => 07662932 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-16 [patent_title] => 'Vascular endothelial growth factor D (VEGF-D) polypeptides and methods of use' [patent_app_type] => utility [patent_app_number] => 11/772089 [patent_app_country] => US [patent_app_date] => 2007-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 22 [patent_no_of_words] => 16010 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/662/07662932.pdf [firstpage_image] =>[orig_patent_app_number] => 11772089 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5016598 [patent_doc_number] => 20070259807 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-08 [patent_title] => 'Growth Factor HTTER36' [patent_app_type] => utility [patent_app_number] => 11/768441 [patent_app_country] => US [patent_app_date] => 2007-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 18979 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0259/20070259807.pdf [firstpage_image] =>[orig_patent_app_number] => 11768441 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4771418 [patent_doc_number] => 20080057076 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-06 [patent_title] => 'Novel fibroblast growth factors' [patent_app_type] => utility [patent_app_number] => 11/821191 [patent_app_country] => US [patent_app_date] => 2007-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 13299 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0057/20080057076.pdf [firstpage_image] =>[orig_patent_app_number] => 11821191 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4759921 [patent_doc_number] => 20080312147 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-18 [patent_title] => 'Compositions and Methods for the Regulation of Hair Growth' [patent_app_type] => utility [patent_app_number] => 11/764040 [patent_app_country] => US [patent_app_date] => 2007-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 2507 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20080312147.pdf [firstpage_image] =>[orig_patent_app_number] => 11764040 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5285389 [patent_doc_number] => 20090099064 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-16 [patent_title] => 'Derivatized insulin oligomers' [patent_app_type] => utility [patent_app_number] => 11/808299 [patent_app_country] => US [patent_app_date] => 2007-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 5836 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20090099064.pdf [firstpage_image] =>[orig_patent_app_number] => 11808299 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5458664 [patent_doc_number] => 20090258816 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-15 [patent_title] => 'USE OF GPCR AGONISTS TO DELAY PROGRESSION OF DIABETES' [patent_app_type] => utility [patent_app_number] => 12/303028 [patent_app_country] => US [patent_app_date] => 2007-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4609 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20090258816.pdf [firstpage_image] =>[orig_patent_app_number] => 12303028 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 270204 [patent_doc_number] => 07563438 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-07-21 [patent_title] => 'FGF homologs and antibodies thereto' [patent_app_type] => utility [patent_app_number] => 11/752197 [patent_app_country] => US [patent_app_date] => 2007-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 25824 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/563/07563438.pdf [firstpage_image] =>[orig_patent_app_number] => 11752197 [rel_patent_id] =>[rel_patent_doc_number] =>)